Skip to main content
. 2015 Jun 15;2015(6):CD007402. doi: 10.1002/14651858.CD007402.pub3

NCT02290821.

Trial name or title A randomised, double‐blind, placebo‐controlled, parallel group study to evaluate the efficacy and safety of diclofenac sodium topical gel (DSG) 1% applied four times daily in subjects with acute blunt soft tissue injuries/contusions of the limbs
Methods R, DB, PC, parallel groups
Participants Acute blunt soft tissue injuries or contusions of the limbs, ≤ 6 hours ("fresh"). Age ≥ 16 years
Estimated enrolment 200
Interventions Diclofenac sodium gel 1% x 4 daily
 Placebo gel
Duration of treatment not reported
Outcomes Pain
Safety
Starting date December 2014
Contact information Novartis
Notes Estimated completion August 2015

AC: active control; DB: double‐blind; PC: placebo‐controlled; PGE: Patient Global Evaluation of treatment; PI: pain intensity; PID: pain intensity difference; PR: pain relief; R: randomised